Skip to main content
DNA Labs India

Immunohistochemistry CD7 Test

DNA Labs India | ISO 9001:2015 Certified

Immunohistochemistry CD7 Test

Short Name: IHC CD7

Also known as: CD7 Immunostain, CD7 IHC, CD7 Antibody Test, Immunohistochemistry CD7 Staining, CD7 Antigen Detection

Immunohistochemistry CD7 Test test available at DNA Labs India for ₹3,500. Uses Immunohistochemistry (IHC), Monoclonal Antibody Staining, Peroxidase-Antiperoxidase Technique on Tumor Tissue (Formalin-fixed paraffin-embedded block or fresh tissue in 10% Formal-saline) samples. Results in Report: Block 5 days | Tissue Biopsy: 5 days | Tissue Large Complex: 7 days. Sample accepted daily by 6 PM.. Free home collection in 300+ cities across India.

ImmunohistochemistryAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The Immunohistochemistry CD7 Test is performed to detect the CD7 antigen on lymphoid tissue sections. It is primarily used to identify T-cell lymphomas and leukemias, differentiate T-cell neoplasms from reactive conditions, and confirm the diagnosis of Mycosis Fungoides and Cutaneous T-cell Lymphoma where loss of CD7 is a characteristic finding. This test aids pathologists and oncologists in accurate classification and staging of the disease.

Test Code
986
CPT Code
88342
ICD Code
C84.7
Price
₹3,500
Sample Type
Tumor Tissue (Formalin-fixed paraffin-embedded block or fresh tissue in 10% Formal-saline)
Result Time
Report: Block 5 days | Tissue Biopsy: 5 days | Tissue Large Complex: 7 days. Sample accepted daily by 6 PM.
Fasting Required
No
Method
Immunohistochemistry (IHC), Monoclonal Antibody Staining, Peroxidase-Antiperoxidase Technique
Step 1

Sample Collection

Provide a copy of the histopathology report, site of biopsy, and clinical history. Ensure tissue is properly fixed in 10% Formal-saline or as a formalin-fixed paraffin-embedded (FFPE) block.

Method: Surgical biopsy, excisional biopsy, incisional biopsy, or core needle biopsy

Step 2

Laboratory Analysis

Sample is collected via biopsy procedure (surgical, excisional, incisional, or core needle) performed by the treating physician or surgeon.

Step 3

Report Delivery

Ensure the specimen is labeled correctly with patient details. Ship at room temperature. Provide complete clinical history and prior pathology reports for accurate interpretation.

Timeline: Report: Block 5 days | Tissue Biopsy: 5 days | Tissue Large Complex: 7 days. Sample accepted daily by 6 PM.

Patient Instructions

1
Before the Test:Provide the histopathology report, biopsy site information, and clinical history to the laboratory. No patient preparation is required as this is a tissue-based test performed on an already collected biopsy specimen.
2
During the Test:The tissue sample undergoes processing, sectioning, and staining with a monoclonal antibody specific to the CD7 antigen. The stained slides are then examined microscopically by a pathologist.
3
After the Test:Results are compiled into a detailed report indicating CD7 expression status, staining pattern, intensity, and pathologist interpretation. The report is delivered via the chosen method (online portal, email, or WhatsApp).

About This Test

Who Should Get This Test

The Immunohistochemistry CD7 Test is performed to detect the CD7 antigen on lymphoid tissue sections. It is primarily used to identify T-cell lymphomas and leukemias, differentiate T-cell neoplasms from reactive conditions, and confirm the diagnosis of Mycosis Fungoides and Cutaneous T-cell Lymphoma where loss of CD7 is a characteristic finding. This test aids pathologists and oncologists in accurate classification and staging of the disease.

How to Prepare

  • Submit tumor tissue in 10% Formal-saline OR as a Formalin-Fixed Paraffin-Embedded (FFPE) block
  • Ship the specimen at room temperature
  • Provide a copy of the histopathology report
  • Mention the exact site of biopsy on the requisition form
  • Include relevant clinical history and suspected diagnosis
  • Label the container clearly with patient name, date, and specimen details

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Immunohistochemistry CD7 is a valuable ancillary marker in the workup of T-cell lymphoproliferative disorders. Aberrant loss of CD7 expression is frequently observed in cutaneous T-cell lymphomas, including Mycosis Fungoides, and helps distinguish neoplastic from reactive T-cell populations. I routinely order this test alongside a panel of T-cell markers (CD2, CD3, CD4, CD5, CD8) to arrive at an accurate diagnosis and guide treatment planning. Patients presenting with persistent skin patches, plaques, or unexplained lymphadenopathy should be evaluated promptly with appropriate immunohistochemical studies."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeTumor Tissue (Formalin-fixed paraffin-embedded block or fresh tissue in 10% Formal-saline)
Sample VolumeAs per biopsy specimen
Container10% Formal-saline container or FFPE block
Collection MethodSurgical biopsy, excisional biopsy, incisional biopsy, or core needle biopsy

Sample Stability

Room Temperature (FFPE block)
Room Temperature (fresh tissue in formal-saline)
Sample Rejection Criteria:
  • Specimen received without proper fixation or in dried condition
  • Specimen without patient identification or requisition form
  • Tissue with extensive necrosis or autolysis making interpretation unreliable
  • Specimen received in expired or inappropriate fixative
  • Absence of clinical history or biopsy site information

Understanding Your Results

The Immunohistochemistry CD7 Test results are interpreted by a qualified pathologist in the context of the patient's clinical presentation, morphology, and other ancillary tests. The presence or absence of CD7 expression helps classify lymphoid neoplasms and guides further management.
📊

Normal CD7 expression is seen on T cells and NK cells. Retained CD7 expression in a lymphoid infiltrate may suggest a reactive process or a T-cell neoplasm that has retained the marker. Correlation with morphology and other markers is essential.

📊

Loss of CD7 expression by neoplastic lymphocytes is considered a distinguishing characteristic of Mycosis Fungoides (MF) and Cutaneous T-cell Lymphoma (CTCL). Aberrant loss of CD7 supports a diagnosis of T-cell lymphoma over a reactive process.

📊

Partial loss of CD7 may be seen in some T-cell lymphoproliferative disorders. This pattern requires correlation with additional immunohistochemical markers, clinical presentation, and histological findings.

⚠️ When to Consult a Doctor:

Consult your doctor if you experience persistent skin patches or plaques, unexplained lumps or swelling in the neck, armpits, or groin, prolonged fever, night sweats, unexplained weight loss, fatigue, itchy skin rashes, or bone pain. These symptoms may warrant investigation for T-cell lymphomas and leukemias, and your doctor may recommend the Immunohistochemistry CD7 Test as part of the diagnostic workup.

Limitations

  • This test evaluates only the CD7 marker and should be interpreted alongside a comprehensive IHC panel
  • Loss of CD7 is not exclusively diagnostic of a specific lymphoma subtype and must be correlated with morphology and clinical context
  • Results may be affected by pre-analytical variables such as tissue fixation and processing quality
  • A negative CD7 result does not rule out T-cell malignancy as some T-cell neoplasms may retain CD7 expression
  • Cannot be used as a standalone diagnostic test; always requires histopathological correlation

Risks & Considerations

  • There are no direct risks associated with this test as it is performed on an already collected tissue specimen
  • The biopsy procedure itself carries minimal risks such as bleeding, infection, or discomfort at the biopsy site, which are managed by the treating physician

Interfering Factors

  • Inadequate fixation of tissue specimen leading to antigen degradation
  • Prolonged storage of paraffin-embedded blocks resulting in loss of antigenicity
  • Over-decalcification of bony tissue specimens
  • Use of fixatives other than 10% neutral buffered formalin
  • Necrotic or heavily inflamed tissue areas may yield non-representative results

Compare With Similar Tests

TestImmunohistochemistry CD7 TestImmunohistochemistry CD3 TestImmunohistochemistry CD4 TestImmunohistochemistry CD8 TestImmunohistochemistry CD30 TestFlow Cytometry Immunophenotyping
ComparisonImmunohistochemistry CD7 Test

Frequently Asked Questions

What is the Immunohistochemistry CD7 Test?
The Immunohistochemistry CD7 Test is a tissue-based diagnostic test that detects the presence or absence of the CD7 antigen on lymphocytes. It is primarily used to help diagnose T-cell lymphomas, T-cell leukemias, Mycosis Fungoides, and Cutaneous T-cell Lymphoma. The test is performed on formalin-fixed paraffin-embedded (FFPE) tissue sections.
Why is the CD7 Test performed?
The CD7 Test is performed to evaluate the immunophenotype of lymphoid neoplasms. It helps identify T-cell lymphomas and leukemias, distinguish neoplastic from reactive T-cell populations, and confirm diagnoses such as Mycosis Fungoides (MF) and Cutaneous T-cell Lymphoma (CTCL) where loss of CD7 is a characteristic feature.
What sample is required for the CD7 Test?
The test requires a tumor tissue sample submitted in 10% Formal-saline or as a Formalin-Fixed Paraffin-Embedded (FFPE) block. The sample is typically obtained through a biopsy procedure such as surgical biopsy, excisional biopsy, incisional biopsy, or core needle biopsy.
How much does the Immunohistochemistry CD7 Test cost at DNA Labs India?
The Immunohistochemistry CD7 Test costs INR 3500 at DNA Labs India. This price includes tissue processing, immunohistochemistry staining, pathologist interpretation, and digital report delivery. Free home sample collection is available in select cities across India.
What does positive CD7 expression mean?
Positive CD7 expression means the CD7 antigen is detected on the surface of lymphocytes in the submitted tissue. Normal T cells and NK cells express CD7. Retained expression may be seen in reactive conditions or some T-cell neoplasms. The result must be interpreted in conjunction with morphology and other markers.
What does loss of CD7 expression indicate?
Loss of CD7 expression by neoplastic lymphocytes is a distinguishing characteristic of Mycosis Fungoides (MF) and Cutaneous T-cell Lymphoma (CTCL). Aberrant loss of CD7 in a lymphoid infiltrate provides supporting evidence for a T-cell lymphoma diagnosis and helps differentiate neoplastic from reactive T-cell populations.
Is the CD7 Test used to diagnose Mycosis Fungoides?
Yes, loss of CD7 expression is considered one of the distinguishing immunohistochemical characteristics of Mycosis Fungoides (MF). The CD7 Test, along with other T-cell markers and clinical correlation, helps confirm the diagnosis of MF and Cutaneous T-cell Lymphoma.
How long does it take to get CD7 Test results?
The turnaround time for the Immunohistochemistry CD7 Test at DNA Labs India is 5-7 working days. Reports for paraffin blocks and tissue biopsies are typically available in 5 days, while large complex tissue specimens may take up to 7 days.
Is fasting required for the Immunohistochemistry CD7 Test?
No, fasting is not required for the Immunohistochemistry CD7 Test. This is a tissue-based test performed on an already collected biopsy specimen, so no special patient preparation or dietary restrictions are needed.
What is the difference between the CD7 IHC Test and flow cytometry?
The CD7 IHC Test is performed on formalin-fixed paraffin-embedded (FFPE) tissue sections and allows spatial visualization of CD7 expression in the tissue architecture. Flow cytometry, on the other hand, uses fresh cell suspensions and provides quantitative data on antigen expression. Both methods complement each other in the diagnosis of T-cell lymphomas.
Is home sample collection available for the CD7 Test?
Yes, DNA Labs India offers free home sample collection for the Immunohistochemistry CD7 Test. This service is available in major cities across India including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, Pune, Ahmedabad, and many more. You can book online to avail this service.
Which doctor should I consult for the CD7 Test?
The Immunohistochemistry CD7 Test is typically ordered by an oncologist, hematologist, or pathologist. If you are experiencing symptoms such as persistent skin lesions, unexplained lymph node enlargement, fever, night sweats, or weight loss, consult an oncologist who may recommend this test as part of the diagnostic workup.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.